Fig. 2From: The anti-diabetic effects of betanin in streptozotocin-induced diabetic rats through modulating AMPK/SIRT1/NF-κB signaling pathwayHistopathological findings of the liver and pancreas following treatments with different doses of betanin (10, 20 and 40 mg/kg.b.w) in SZT-induced diabetic and normal rats (the images above are related to liver tissue and the images below are related to pancreatic tissue)Back to article page